Events

Notificaciones De Seguridad De Campo acerca de mmt-326a and mmt-332a insulin reservoirs for paradigm insulin pumps

Según Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, este evento ( notificaciones de seguridad de campo ) involucró a un dispositivo médico en Poland que fue producido por Medtronic MiniMed.

¿Qué es esto?

Las notificaciones de seguridad de campo son comunicaciones sobre acciones que se pueden estar tomando en relación con un producto que se encuentra en el mercado, enviadas por los fabricantes de dispositivos médicos o sus representantes. Estas notificaciones son principalmente para trabajadores de la salud, pero también para usuarios. Pueden incluir alertas y retiro de equipos.

Más información acerca de la data acá
  • Tipo de evento
    Field Safety Notice
  • ID del evento
    2674
  • Fecha
    2013-07-17
  • País del evento
    Poland
  • Fuente del evento
    ORMPMDBP
  • URL de la fuente del evento
    http://www.urpl.gov.pl/pl/notatka-bezpiecze%C5%84stwa-firmy-medtronic-minimed-dotycz%C4%85ca-wycofania-z-obrotu-i-z-u%C5%BCywania-zbiornik%C3%B3w
  • Notas / Alertas
    Polish data is current through November 2018. All of the data comes from the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Poland.
  • Notas adicionales en la data
  • Acción
    Medtronic MiniMed safety note regarding the withdrawal and use of MMT-326A and MMT-332A insulin reservoirs for Paradigm insulin pumps

Device

mmt-326a and mmt-332a insulin reservoirs for paradigm insulin pumps

Manufacturer

Medtronic MiniMed
  • Empresa matriz del fabricante (2017)
    Medtronic plc
  • Comentario del fabricante
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    ORMPMDBP